Harrower A D, McFarlane G, Donnelly T, Gray C E
Hypertension. 1985 Nov-Dec;7(6 Pt 2):II161-3. doi: 10.1161/01.hyp.7.6_pt_2.ii161.
Ten hypertensive non-insulin-dependent diabetic patients were treated with the antihypertensive drug indapamide to assess its effect on glucose tolerance over 1 year. Both systolic and diastolic blood pressures fell significantly (p less than 0.001) over the first month of treatment, and no change in plasma glucose or plasma insulin levels during an oral glucose tolerance test occurred at any time. Indapamide is an effective antihypertensive drug and, in contrast to thiazide diuretics, has no adverse effect on glucose tolerance in non-insulin-dependent diabetic patients.
十名高血压非胰岛素依赖型糖尿病患者接受了抗高血压药物吲达帕胺治疗,以评估其对糖耐量的影响,为期一年。在治疗的第一个月,收缩压和舒张压均显著下降(p<0.001),且在口服葡萄糖耐量试验期间,血浆葡萄糖或血浆胰岛素水平在任何时候均未发生变化。吲达帕胺是一种有效的抗高血压药物,与噻嗪类利尿剂不同,它对非胰岛素依赖型糖尿病患者的糖耐量没有不良影响。